HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lynda Szczech Selected Research

roxadustat

3/2022Retraction notice to "Pooled Analysis of Roxadustat for Anemia in Patients With Kidney Failure Incident to Dialysis." Kidney Int Rep. 2021;6:613-623.
7/2021A Randomized Trial of Roxadustat in Anemia of Kidney Failure: SIERRAS Study.
3/2021Roxadustat for CKD-related Anemia in Non-dialysis Patients.
3/2021Pooled Analysis of Roxadustat for Anemia in Patients With Kidney Failure Incident to Dialysis.
1/2021Efficacy and Cardiovascular Safety of Roxadustat for Treatment of Anemia in Patients with Non-Dialysis-Dependent CKD: Pooled Results of Three Randomized Clinical Trials.
1/2021Roxadustat for anemia in patients with end-stage renal disease incident to dialysis.
12/2019Roxadustat for Anemia in Patients with Kidney Disease Not Receiving Dialysis.
12/2019Roxadustat Treatment for Anemia in Patients Undergoing Long-Term Dialysis.
8/2017Phase 2 studies of oral hypoxia-inducible factor prolyl hydroxylase inhibitor FG-4592 for treatment of anemia in China.
6/2016Roxadustat (FG-4592) Versus Epoetin Alfa for Anemia in Patients Receiving Maintenance Hemodialysis: A Phase 2, Randomized, 6- to 19-Week, Open-Label, Active-Comparator, Dose-Ranging, Safety and Exploratory Efficacy Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lynda Szczech Research Topics

Disease

11Anemia
03/2022 - 11/2006
10Chronic Renal Insufficiency
03/2021 - 11/2006
8Hypoxia (Hypoxemia)
07/2021 - 06/2016
7Chronic Kidney Failure (Chronic Renal Failure)
07/2021 - 08/2002
3Renal Insufficiency (Renal Failure)
03/2022 - 03/2021
3Myocardial Infarction
03/2021 - 11/2006
3Stroke (Strokes)
03/2021 - 11/2006
3Heart Failure
03/2021 - 11/2006
3Kidney Diseases (Kidney Disease)
12/2019 - 12/2008
2Unstable Angina
03/2021 - 01/2021
2Hyperkalemia
12/2019 - 12/2019
2Diabetes Mellitus
01/2003 - 08/2002
1Hypertension (High Blood Pressure)
12/2019
1Infections
12/2019
1Acidosis
12/2019
1Viremia
04/2013
1Hepatitis C
04/2013
1Albuminuria
01/2011
1Acute Kidney Injury (Acute Renal Failure)
09/2010
1Arteriovenous Fistula
08/2002

Drug/Important Bio-Agent (IBA)

10roxadustatIBA
03/2022 - 06/2016
7Prolyl-Hydroxylase InhibitorsIBA
07/2021 - 06/2016
6Epoetin Alfa (Epogen)FDA Link
07/2021 - 11/2006
6Hemoglobins (Hemoglobin)IBA
03/2021 - 11/2006
6IronIBA
03/2021 - 01/2003
4ErythropoietinFDA Link
07/2021 - 11/2006
2HematinicsIBA
07/2021 - 11/2013
2omega-Chloroacetophenone (Mace)IBA
03/2021 - 01/2021
2AlbuminsIBA
01/2011 - 01/2003
2CreatinineIBA
01/2011 - 12/2008
1Prolyl Hydroxylases (Prolyl Hydroxylase)IBA
12/2019
1Transcription Factors (Transcription Factor)IBA
08/2017
1HepcidinsIBA
06/2016
1RNA (Ribonucleic Acid)IBA
04/2013
1Biomarkers (Surrogate Marker)IBA
04/2013
1Protease Inhibitors (Protease Inhibitor)IBA
04/2013
1Cystatin CIBA
09/2010
1Tenofovir (Viread)FDA Link
12/2008
1Transferrin (beta 2 Transferrin)IBA
01/2003
1Serum AlbuminIBA
08/2002

Therapy/Procedure

5Therapeutics
01/2021 - 12/2008
1Renal Dialysis (Hemodialysis)
06/2016
1Erythrocyte Transfusion
11/2013
1Renal Replacement Therapy (Therapies, Renal Replacement)
11/2006
1Catheters
08/2002